-
Electronic (PDF)
-
Site License
-
Enterprisewide
South and Central America In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
GlobalData, December 2012, Pages: 197
South and Central America In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
Summary
Our new report, “South and Central America In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the South and Central America In Vitro Diagnostics Market – Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Countries covered include Argentina, Brazil and Mexico..
- Market size and company share data for In Vitro Diagnostics market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the South and Central America In Vitro Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Alere Inc., Bio-Rad Laboratories, Inc., Ortho-Clinical Diagnostics Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Sysmex Corporation, DiaSorin S.p.A, Horiba, Ltd., Mindray Medical International Limited, Phadia AB, Thermo Fisher Scientific Inc. and Qiagen N.V.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South and Central America In Vitro Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics in South and Central America
3.1 In Vitro Diagnostics Cross Country Comparison
3.2 In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics, South and Central America, Company share (2010-2011)
4 In Vitro Diagnostics In Argentina
4.1 In Vitro Diagnostics, Argentina, Distribution Share (2010-2011)
4.1.1 Clinical Chemistry, Argentina, Distribution Share (2010-2011)
4.1.2 Genetic Testing, Argentina, Distribution Share (2010-2011)
4.1.3 Haematology, Argentina, Distribution Share (2010-2011)
4.1.4 Histology And Cytology, Argentina, Distribution Share (2010-2011)
4.1.5 Immuno Chemistry, Argentina, Distribution Share (2010-2011)
4.1.6 Infectious Immunology, Argentina, Distribution Share (2010-2011)
4.1.7 Microbiology Culture, Argentina, Distribution Share (2010-2011)
4.2 In Vitro Diagnostics, Argentina, Company Share (2010-2011)
4.2.1 In Vitro Diagnostics, Argentina, Company Share (2010-2011)
4.2.2 Clinical Chemistry, Argentina, Company Share (2010-2011)
4.2.3 Genetic Testing, Argentina, Company Share (2010-2011)
4.2.4 Haematology, Argentina, Company Share (2010-2011)
4.2.5 Histology And Cytology, Argentina, Company Share (2010-2011)
4.2.6 Immuno Chemistry, Argentina, Company Share (2010-2011)
4.2.7 Infectious Immunology, Argentina, Company Share (2010-2011)
4.2.8 Microbiology Culture, Argentina, Company Share (2010-2011)
5 In Vitro Diagnostics In Brazil
5.1 In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
5.2 In Vitro Diagnostics, Brazil, Distribution Share (2010-2011)
5.2.1 Clinical Chemistry, Brazil, Distribution Share (2010-2011)
5.2.2 Genetic Testing, Brazil, Distribution Share (2010-2011)
5.2.3 Haematology, Brazil, Distribution Share (2010-2011)
5.2.4 Histology And Cytology, Brazil, Distribution Share (2010-2011)
5.2.5 Immuno Chemistry, Brazil, Distribution Share (2010-2011)
5.2.6 Infectious Immunology, Brazil, Distribution Share (2010-2011)
5.2.7 Microbiology Culture, Brazil, Distribution Share (2010-2011)
5.3 In Vitro Diagnostics, Brazil, Company Share (2010-2011)
5.3.1 In Vitro Diagnostics, Brazil, Company Share (2010-2011)
5.3.2 Clinical Chemistry, Brazil, Company Share (2010-2011)
5.3.3 Genetic Testing, Brazil, Company Share (2010-2011)
5.3.4 Haematology, Brazil, Company Share (2010-2011)
5.3.5 Histology And Cytology, Brazil, Company Share (2010-2011)
5.3.6 Immuno Chemistry, Brazil, Company Share (2010-2011)
5.3.7 Infectious Immunology, Brazil, Company Share (2010-2011)
5.3.8 Microbiology Culture, Brazil, Company Share (2010-2011)
6 In Vitro Diagnostics In Mexico
6.1 In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Constant, 2004-2018
6.2 In Vitro Diagnostics, Mexico, Distribution Share (2010-2011)
6.2.1 Clinical Chemistry, Mexico, Distribution Share (2010-2011)
6.2.2 Genetic Testing, Mexico, Distribution Share (2010-2011)
6.2.3 Haematology, Mexico, Distribution Share (2010-2011)
6.2.4 Histology And Cytology, Mexico, Distribution Share (2010-2011)
6.2.5 Immuno Chemistry, Mexico, Distribution Share (2010-2011)
6.2.6 Infectious Immunology, Mexico, Distribution Share (2010-2011)
6.2.7 Microbiology Culture, Mexico, Distribution Share (2010-2011)
6.3 In Vitro Diagnostics, Mexico, Company Share (2010-2011)
6.3.1 In Vitro Diagnostics, Mexico, Company Share (2010-2011)
6.3.2 Clinical Chemistry, Mexico, Company Share (2010-2011)
6.3.3 Genetic Testing, Mexico, Company Share (2010-2011)
6.3.4 Haematology, Mexico, Company Share (2010-2011)
6.3.5 Histology And Cytology, Mexico, Company Share (2010-2011)
6.3.6 Immuno Chemistry, Mexico, Company Share (2010-2011)
6.3.7 Infectious Immunology, Mexico, Company Share (2010-2011)
6.3.8 Microbiology Culture, Mexico, Company Share (2010-2011)
7 Overview of Key Companies in South and Central America In Vitro Diagnostics Market
7.1 F. Hoffmann-La Roche Ltd.
7.1.1 Company Overview
7.1.2 Share in the South and Central America In Vitro Diagnostics Market
7.2 Siemens Healthcare
7.2.1 Company Overview
7.2.2 Share in the South and Central America In Vitro Diagnostics Market
7.3 Abbott Laboratories
7.3.1 Company Overview
7.3.2 Share in the South and Central America In Vitro Diagnostics Market
7.4 bioMerieux S.A.
7.4.1 Company Overview
7.4.2 Share in the South and Central America In Vitro Diagnostics Market
7.5 Alere Inc.
7.5.1 Company Overview
7.5.2 Share in the South and Central America In Vitro Diagnostics Market
7.6 Bio-Rad Laboratories, Inc.
7.6.1 Company Overview
7.6.2 Share in the South and Central America In Vitro Diagnostics Market
7.7 Ortho-Clinical Diagnostics Inc.
7.7.1 Company Overview
7.8 Beckman Coulter, Inc.
7.8.1 Company Overview
7.9 Becton, Dickinson and Company
7.9.1 Company Overview
7.10 Sysmex Corporation
7.10.1 Company Overview
7.11 DiaSorin S.p.A
7.11.1 Company Overview
7.12 Horiba, Ltd.
7.12.1 Company Overview
7.13 Mindray Medical International Limited
7.13.1 Company Overview
7.14 Phadia AB
7.14.1 Company Overview
7.15 Thermo Fisher Scientific Inc.
7.15.1 Company Overview
7.16 Qiagen N.V.
7.16.1 Company Overview
7.17 PerkinElmer, Inc.
7.17.1 Company Overview
7.18 Gen-Probe Incorporated
7.18.1 Company Overview
7.19 ELITech Group
7.19.1 Company Overview
7.20 Grifols, S.A.
7.20.1 Company Overview
7.21 Diagnostica Stago, Inc.
7.21.1 Company Overview
7.22 Danaher Corporation
7.22.1 Company Overview
7.23 Life Technologies Corporation
7.23.1 Company Overview
7.24 Gen-Probe Incorporated
7.24.1 Company Overview
8 In Vitro Diagnostics Market Pipeline Products
8.1 Clinical Chemisty Market Pipeline Products
8.2 Immuno Chemistry Market Pipeline Products
8.3 Haematology Market Pipeline Products
8.4 Infectious Immunology Market Pipeline Products
8.5 Microbiology Culture Market Pipeline Products
8.6 Histology And Cytology Market Pipeline Products
8.7 Genetic Testing Market Pipeline Products
9 Financial Deals Landscape
9.1 Partnerships
9.1.1 Cisbio Bioassays Enters Into Distribution Agreement With BellBrook Labs For Transcreener Epigen Methyltransferase Assay
9.1.2 bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
9.1.3 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
9.1.4 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
9.1.5 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
9.1.6 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
9.1.7 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
9.1.8 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
9.1.9 Atossa Enters Into Co-Marketing Agreement With Diagnostics Test Group For MASCT System
9.1.10 CML HealthCare Enters Into Agreement With MaRS Innovation
9.1.11 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
9.1.12 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
9.1.13 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
9.1.14 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
9.1.15 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
9.1.16 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
9.1.17 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
9.1.18 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
9.1.19 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
9.1.20 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
9.1.21 One Lambda Enters Into Co-Marketing Agreement With CellTrend
9.1.22 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
9.1.23 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
9.1.24 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
9.1.25 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
9.1.26 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
9.1.27 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
9.1.28 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
9.1.29 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
9.1.30 LipoScience Enters Into Licensing Agreement With Cleveland Clinic
9.1.31 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
9.1.32 Sysmex Extends Distribution Agreement With Roche
9.1.33 NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
9.1.34 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
10 Recent Developments
10.1 Strategy And Business Planning
10.1.1 Mar 12, 2012: AB SCIEX Expands Commercial Operations In Brazil
10.1.2 Jan 19, 2012: Nihon Kohden Establishes Sales Subsidiary In Brazil
11 Appendix
11.1 Definitions of Markets Covered in the Report
11.1.1 In Vitro Diagnostics
11.2 Research Methodology
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Forecasts
11.7 Expert Panels
11.8 Consulting
11.9 Currency Conversion
11.10 Contact Us
11.11 Disclaimer
1.1 List of Tables
Table 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018
Table 2: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018
Table 3: Diagnostic Imaging, South and Central America, Cross-Category Analysis, 2004-2018
Table 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: In Vitro Diagnostics, South and Central America, Company share by Revenue ($m), USD Constant, 2010-2011
Table 7: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, 2004-2018
Table 8: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 9: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 10: Clinical Chemistry, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 11: Genetic Testing, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 12: Haematology, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 13: Histology And Cytology, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 14: Immuno Chemistry, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Infectious Immunology, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Microbiology Culture, Argentina, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 17: In Vitro Diagnostics, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 18: Clinical Chemistry, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 19: Genetic Testing, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Haematology, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Histology And Cytology, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 22: Immuno Chemistry, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 23: Infectious Immunology, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 24: Microbiology Culture, Argentina, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 25: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
Table 26: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 27: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 28: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Genetic Testing, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 30: Haematology, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 31: Histology And Cytology, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 33: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 34: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: In Vitro Diagnostics, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Clinical Chemistry, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 37: Genetic Testing, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 38: Haematology, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 39: Histology And Cytology, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 40: Immuno Chemistry, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Infectious Immunology, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 42: Microbiology Culture, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 43: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Constant, 2004-2018
Table 44: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 45: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 46: Clinical Chemistry, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 47: Genetic Testing, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 48: Haematology, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 49: Histology And Cytology, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Immuno Chemistry, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Infectious Immunology, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 52: Microbiology Culture, Mexico, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 53: In Vitro Diagnostics, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 54: Clinical Chemistry, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 55: Genetic Testing, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 56: Histology And Cytology, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Histology And Cytology, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 58: Immuno Chemistry, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Infectious Immunology, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 60: Microbiology Culture, Mexico, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 61: Clinical Chemisty Market Pipeline Products
Table 62: Immuno Chemistry Market Pipeline Products
Table 63: Haematology Market Pipeline Products
Table 64: Infectious Immunology Market Pipeline Products
Table 65: Microbiology Culture Market Pipeline Products
Table 66: Histology And Cytology Market Pipeline Products
Table 67: Genetic Testing Market Pipeline Products
Table 68: Cisbio Bioassays Enters Into Distribution Agreement With BellBrook Labs For Transcreener Epigen Methyltransferase Assay
Table 69: bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology
Table 70: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
Table 71: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
Table 72: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
Table 73: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
Table 74: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Table 75: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
Table 76: Atossa Enters Into Co-Marketing Agreement With Diagnostics Test Group For MASCT System
Table 77: CML HealthCare Enters Into Agreement With MaRS Innovation
Table 78: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
Table 79: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
Table 80: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
Table 81: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
Table 82: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Table 83: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
Table 84: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Table 85: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
Table 86: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
Table 87: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
Table 88: One Lambda Enters Into Co-Marketing Agreement With CellTrend
Table 89: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Table 90: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
Table 91: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
Table 92: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
Table 93: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
Table 94: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
Table 95: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
Table 96: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
Table 97: LipoScience Enters Into Licensing Agreement With Cleveland Clinic
Table 98: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
Table 99: Sysmex Extends Distribution Agreement With Roche
Table 100: NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
Table 101: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX
1.2 List of Figures
Figure 1: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018
Figure 2: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: In Vitro Diagnostics, South and Central America, Cross-Category Analysis, 2004-2018
Figure 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 5: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 6: In Vitro Diagnostics, South and Central America, Company share (%), 2011
Figure 7: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, 2004-2018
Figure 8: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 9: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 10: In Vitro Diagnostics, Argentina, Company Share (%), 2011
Figure 11: Clinical Chemistry, Argentina, Company Share (%), 2011
Figure 12: Genetic Testing, Argentina, Company Share (%), 2011
Figure 13: Haematology, Argentina, Company Share (%), 2011
Figure 14: Histology And Cytology, Argentina, Company Share (%), 2011
Figure 15: Immuno Chemistry, Argentina, Company Share (%), 2011
Figure 16: Infectious Immunology, Argentina, Company Share (%), 2011
Figure 17: Microbiology Culture, Argentina, Company Share (%), 2011
Figure 18: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
Figure 19: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 20: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 21: In Vitro Diagnostics, Brazil, Company Share (%), 2011
Figure 22: Clinical Chemistry, Brazil, Company Share (%), 2011
Figure 23: Genetic Testing, Brazil, Company Share (%), 2011
Figure 24: Haematology, Brazil, Company Share (%), 2011
Figure 25: Histology And Cytology, Brazil, Company Share (%), 2011
Figure 26: Immuno Chemistry, Brazil, Company Share (%), 2011
Figure 27: Infectious Immunology, Brazil, Company Share (%), 2011
Figure 28: Microbiology Culture, Brazil, Company Share (%), 2011
Figure 29: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Constant, 2004-2018
Figure 30: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 31: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 32: In Vitro Diagnostics, Mexico, Company Share (%), 2011
Figure 33: Clinical Chemistry, Mexico, Company Share (%), 2011
Figure 34: Genetic Testing, Mexico, Company Share (%), 2011
Figure 35: Haematology, Mexico, Company Share (%), 2011
Figure 36: Histology And Cytology, Mexico, Company Share (%), 2011
Figure 37: Immuno Chemistry, Mexico, Company Share (%), 2011
Figure 38: Infectious Immunology, Mexico, Company Share (%), 2011
Figure 39: Microbiology Culture, Mexico, Company Share (%), 2011
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%), South and Central America In Vitro Diagnostics Market, 2011
Figure 41: Siemens Healthcare, Company Share (%), South and Central America In Vitro Diagnostics Market, 2011
Figure 42: Abbott Laboratories, Company Share (%), South and Central America In Vitro Diagnostics Market, 2011
Figure 43: bioMerieux S.A., Company Share (%), South and Central America In Vitro Diagnostics Market, 2011
Figure 44: Alere Inc., Company Share (%), South and Central America In Vitro Diagnostics Market, 2011
Figure 45: Bio-Rad Laboratories, Inc., Company Share (%), South and Central America In Vitro Diagnostics Market, 2011
F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
bioMerieux S.A.
Alere Inc.
Bio-Rad Laboratories, Inc.
Ortho-Clinical Diagnostics Inc.
Beckman Coulter, Inc.
Becton, Dickinson and Company
Sysmex Corporation
DiaSorin S.p.A
Horiba, Ltd.
Mindray Medical International Limited
Phadia AB
Thermo Fisher Scientific Inc.
Qiagen N.V.
PerkinElmer, Inc.
Gen-Probe Incorporated
ELITech Group
Grifols, S.A.
Diagnostica Stago, Inc.
Danaher Corporation
Life Technologies Corporation
Gen-Probe Incorporated
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
